Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus

Phase 2

Completed

• Conditions: Long Acting Insulin in Control of Gestational Diabetes Mellitus
• Interventions: Drug: multiple dose regimen; Drug: Long acting insulin

• Registration Number: NCT04674332
• Lead Sponsor: Ain Shams University

Brief Summary

multiple dose regimen as a standard treatment for gestational diabetes will be compared to long acting insulin

Detailed Description

Not available

Study Timeline

• Study Start: 2019-09-01
• Primary Completion: 2020-12-14
• Study Completion: 2020-12-14
• Study First Submitted: 2020-12-14
• Study First Submitted QC: 2020-12-14
• Study First Posted: 2020-12-19
• Status Verified: 2021-09
• Last Update Submitted: 2021-09-04
• Last Update Posted: 2021-09-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 148

Inclusion Criteria

• pregnant women with gestational diabetes mellitus
• between 24-28 weeks gestation

Exclusion Criteria

• other endocrinological abnormalities

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
multiple dose regimen	multiple dose regimen	-
long acting insulin	Long acting insulin	-

Primary Outcome Measures

Name	Time	Method
time needed to achieve glycemic control	1 year	glycemic control assessed by fasting and postprandial blood sugar

Trial Locations

Locations (1)

Ain Shams University Maternity Hospital; 🇪🇬 Cairo, Egypt